Production (Stage)
CervoMed Inc.
CRVO
$7.26
$0.141.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.92M | 2.16M | 1.94M | 3.29M | 2.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.92M | 2.16M | 1.94M | 3.29M | 2.35M |
| Cost of Revenue | 4.84M | 7.09M | 5.13M | -- | 2.81M |
| Gross Profit | -2.92M | -4.92M | -3.19M | 3.29M | -467.00K |
| SG&A Expenses | 2.38M | 2.32M | 2.21M | 2.51M | 2.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.22M | 9.40M | 7.34M | 6.28M | 4.94M |
| Operating Income | -5.30M | -7.24M | -5.40M | -3.00M | -2.59M |
| Income Before Tax | -4.89M | -6.71M | -4.75M | -2.32M | -2.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.89M | -6.71M | -4.75M | -2.32M | -2.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.89M | -6.71M | -4.75M | -2.32M | -2.51M |
| EBIT | -5.30M | -7.24M | -5.40M | -3.00M | -2.59M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.56 | -0.77 | -0.55 | -0.27 | -0.41 |
| Normalized Basic EPS | -0.35 | -0.48 | -0.34 | -0.17 | -0.25 |
| EPS Diluted | -0.56 | -0.77 | -0.55 | -0.27 | -0.41 |
| Normalized Diluted EPS | -0.35 | -0.48 | -0.34 | -0.17 | -0.25 |
| Average Basic Shares Outstanding | 8.70M | 8.71M | 8.70M | 8.70M | 6.17M |
| Average Diluted Shares Outstanding | 8.70M | 8.71M | 8.70M | 8.70M | 6.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |